Keyword: Pharmaceuticals

News

AbbVie Hikes Bid for Shire to $51 Billion

09.07.2014 - US drugmaker AbbVie has raised its offer for London-based pharmaceutical producer Shire to £30.1 billion ($51.3 billion), hoping to win over its reluctant target after three...

News

Belgium's Omega Pharma May Sell Itself

08.07.2014 - Omega Pharma, a Belgian healthcare products distributor, is considering selling itself nearly three years after it was taken private by its founder, the news agency Bloomberg said...

News

Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

03.07.2014 - Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...

News

Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

30.06.2014 - The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...

News

Shire Rejects AbbVie's £27 Billion Takeover Bid

24.06.2014 - British drugmaker Shire has rejected a £27 billion ($46 billion) takeover offer from AbbVie, the latest attempt by a US healthcare firm to tap into lower tax rates abroad via an...

News

Former Novartis Employee Suspected of Data Manipulation

12.06.2014 - A former employee of Novartis Pharma KK, the Japan unit of the Swiss drugmaker, has been arrested on suspicion of manipulating data to promote the company's best-selling blood...

News

Alexion Recalls Certain Lots of Intravenous Drug Soliris

03.06.2014 - US drugmaker Alexion Pharmaceuticals said it is voluntarily recalling certain lots of Soliris, an intravenous drug for two potentially fatal blood disorders that can damage the...

News

Novo Nordisk Launches Diabetes Drug in Germany After Rethink

02.06.2014 - Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...